Home
About
Overview
Sharing Data
ORCID
Help
History (50)
Non-Hodgkin's lymphoma presenting nine years after ileal-pouch ileoanal anastomosis for ulcerative colitis.
The 'tipping point' applied.
American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-a biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.
Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program.
See All 50 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program.
Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci. 1989 Oct; 34(10):1536-41.
View in:
PubMed
subject areas
Age Factors
Carcinoma
Colitis, Ulcerative
Colonic Neoplasms
Colonoscopy
Female
Humans
Intestinal Mucosa
Male
Prospective Studies
Risk Factors
Survival Analysis
Time Factors
authors with profiles
Stephen B. Hanauer